相似文献
1
Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER.
Front Pharmacol. 2024 May 1;15:1413058. doi: 10.3389/fphar.2024.1413058. eCollection 2024.
2
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.
Cells. 2023 Feb 18;12(4):653. doi: 10.3390/cells12040653.
3
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
Cells. 2019 Jun 14;8(6):590. doi: 10.3390/cells8060590.
4
Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
Front Endocrinol (Lausanne). 2020 Sep 30;11:563165. doi: 10.3389/fendo.2020.563165. eCollection 2020.
5
Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Mol Endocrinol. 2010 May;24(5):969-80. doi: 10.1210/me.2009-0148. Epub 2010 Mar 8.
6
Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
BMC Cancer. 2015 Oct 15;15:702. doi: 10.1186/s12885-015-1699-6.
7
GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer.
Expert Opin Ther Targets. 2017 Aug;21(8):755-766. doi: 10.1080/14728222.2017.1350264. Epub 2017 Jul 12.
8
The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
Gene. 2023 Aug 15;877:147548. doi: 10.1016/j.gene.2023.147548. Epub 2023 Jun 4.
9
GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.
Horm Cancer. 2014 Jun;5(3):146-160. doi: 10.1007/s12672-014-0174-1. Epub 2014 Apr 10.
10
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Breast Cancer Res. 2012 Jan 17;14(1):R12. doi: 10.1186/bcr3096.
本文引用的文献
1
Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer.
Front Cell Dev Biol. 2024 Feb 27;12:1338448. doi: 10.3389/fcell.2024.1338448. eCollection 2024.
2
The G protein-coupled oestrogen receptor GPER in health and disease: an update.
Nat Rev Endocrinol. 2023 Jul;19(7):407-424. doi: 10.1038/s41574-023-00822-7. Epub 2023 May 16.
3
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.
Cells. 2023 Feb 18;12(4):653. doi: 10.3390/cells12040653.
4
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.
Sci Rep. 2023 Jan 24;13(1):1326. doi: 10.1038/s41598-023-28062-9.
5
Deciphering of a Putative GPER Recognition Domain in ERα and ERα36.
Front Endocrinol (Lausanne). 2022 Jun 30;13:943343. doi: 10.3389/fendo.2022.943343. eCollection 2022.
6
Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons.
eNeuro. 2022 Jul 15;9(4). doi: 10.1523/ENEURO.0475-21.2022. Print 2022 Jul-Aug.
7
The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice.
Front Endocrinol (Lausanne). 2021 Mar 17;12:578250. doi: 10.3389/fendo.2021.578250. eCollection 2021.
8
G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases.
Front Endocrinol (Lausanne). 2020 Nov 12;11:578536. doi: 10.3389/fendo.2020.578536. eCollection 2020.
9
G Protein-Coupled Estrogen Receptor in Immune Cells and Its Role in Immune-Related Diseases.
Front Endocrinol (Lausanne). 2020 Oct 2;11:579420. doi: 10.3389/fendo.2020.579420. eCollection 2020.
10
Female Heart Health: Is GPER the Missing Link?
Front Endocrinol (Lausanne). 2020 Jan 14;10:919. doi: 10.3389/fendo.2019.00919. eCollection 2019.
Zotero 插件